Zum Inhalt springen

For information & educational purposes only — not medical advice, no dosing or usage recommendation.

Machine-assisted translation — the German original version is authoritative.

Growth Hormone System

Growth Hormone System

GHRP-6

Growth Hormone Releasing Peptide-6 · SKF-110679

Not approved

GHRP-6 is the first synthetic hexapeptide, characterized in 1984, that releases growth hormone specifically and dose-dependently — via a mechanism independent of GHRH (the ghrelin receptor). It is not approved for any human use and, as a ghrelin mimetic, triggers a pronounced hunger reaction. Historically it was the tool with which the ghrelin signaling pathway was discovered in the first place.

Regulatory status

Not approved for humans

Not approved; in sport (WADA) banned at all times.

Drug class

Synthetic GH secretagogue (ghrelin receptor agonist), hexapeptide

Half-life (informative)

Short (in the range of minutes).

Studied in the literature

In studies subcutaneously or intravenously.

Mechanism of action

GHRP-6

GHRP-6 is a GHS-R1a agonist: it triggers a GH release and at the same time markedly stimulates appetite. This hunger reaction is more pronounced than with GHRP-2.

Acts via the body's own GH axis; the strong appetite stimulation is characteristic.

Research history

Cyril Bowers described GHRP-6 in 1984 as the first evidence that a synthetic peptide can release GH independently of GHRH. This paved the way for the discovery of the body's own ligand, ghrelin (1999).

Regulatory status by region

EU / USA·Not approved

No approval for human use.

Sport·Banned (WADA S2)

GH secretagogues are on the WADA Prohibited List at all times.

Research areas

  • Research on the GH axis
  • Ghrelin signaling pathway
  • Appetite and energy balance

Documented effects (from the literature)

  • Pronounced hunger.
  • Rise in GH and IGF-1, fluid retention.
  • Elevation of cortisol and prolactin possible.

Safety concerns & caution

  • As with GHRP-2, chronic use outside a medical indication is unstudied.
  • The pronounced appetite can be undesirable.

Risks of gray-market purchase

  • Traded as a "research" peptide without medicinal-product control.
  • Identity, purity, and content are unknown.

Frequently asked questions

How does GHRP-6 differ from GHRP-2?

Both are ghrelin mimetics that release GH. GHRP-6 triggers a stronger hunger, GHRP-2 releases more GH per microgram. Neither of the two is approved for human use.

Sources

Primary and reference sources for your own reading.

Related substances

Unfamiliar terms? Look them up in the glossary or read the fundamentals.

This profile is for information and education only. It is not medical advice and deliberately contains no dosing or usage details. Decisions about use belong in a doctor’s hands.